PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Boosts Forecast on Soaring GLP-1 Sales

Novo Nordisk A/S raised its forecast for the second time this year, citing higher expectations for its obesity and diabetes drug sales.

4 Aug, 16:48 — 4 Aug, 16:48
PostShare